Provider
Erectile Dysfunction - Phosphodiesterase Type 5 Inhibitors, Topical Prostaglandin - Commercial
Quantity Limit
Program effective Date: Apr 01, 2025
Documents & Forms Results
Displaying 361 - 370 of 3159 results
Provider
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Alternative Dosage Form - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Hympavzi™ - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
P16-25 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Apr 01, 2025
Provider
P15-25 New Claim Edits for Professional Lab Claims Missing Required Data
Program effective Date: Apr 01, 2025
Provider
P19-25 New and Updated Reimbursement Policies
Program effective Date: Apr 01, 2025
Provider
P18-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Program effective Date: Apr 01, 2025
Provider
P14-25 eviCore Healthcare Specialty Utilization Management (UM) Program: Sleep Management Clinical Guideline Updates
Program effective Date: Apr 01, 2025
Provider
P13-25 Payer ID 00562 to be Disabled on June 1, 2025
Program effective Date: Apr 01, 2025